Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

More than 20k people on oral weight loss pill

Digest more
Top News
Overview
Highlights
 · 2d
More than 20k people on oral weight loss pill as Lilly ramps up access
More than 20,000 people are taking Eli Lilly's new GLP-1 weight loss pill approved earlier this month, and company executives expect that number to keep growing as Lilly continues its hold on the weig...

Continue reading

 · 29d
FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know
 · 18d · on MSN
Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots
 · 1d
Lilly's obesity pill hits nearly 6,000 prescriptions in third week after launch
Eli Lilly's (LLY.N) newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times ​in the U.S. in the third week after its launch, ‌according to analysts citing IQVIA data.

Continue reading

 · 1d
Assessing Eli Lilly (LLY) Valuation After A Strong Multi Year Share Price Run
 · 1d
Eli Lilly Sales Surge 56% as Booming GLP-1 Demand Eclipses Lower Prices
 · 1d
Why Eli Lilly (LLY) Stock Is Trading Up Today
The pharmaceutical giant announced that its first-quarter revenue grew 56% to $19.8 billion, significantly beating analyst forecasts.

Continue reading

 · 1d
Eli Lilly Stock Popped on Earnings. America Can’t Get Enough of Its GLP-1s.
 · 1d
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Crispr Therapeutics AG (CRSP)
15h

Scientists discover enzyme that could supercharge Ozempic-like weight-loss drugs

Researchers at the University of Utah have discovered an enzyme called Pap B that will chemically change and update drugs like Ozempic and Wegovy making them stronger and last longer.
6don MSN

Your body already has a built-in weight loss system that works like Wegovy, Ozempic and Mounjaro – food and your gut microbiome

Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for weight loss and blood sugar control.
2d

Weight loss jab Wegovy 'helps people cut down on alcohol'

Weekly injection semaglutide - sold under brand names Wegovy and Ozempic - helped addicts cut number of heavy drinking days each month
11h

FDA wants to limit compounded versions of weight loss drugs

The Food and Drug Administration has proposed removing popular weight loss drugs such as Ozempic and Wegovy from a key compounding list, a move that could limit large‑scale production by outsourcing facilities.
2d

People with alcohol problems could benefit from taking weight loss jabs, researchers find

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol cravings
3d

Weight-loss medication linked to muscle loss

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose husband found a solution for seborrheic dermatitis on his scalp.
1d

US could spend $1 trillion on medications. On top? Weight-loss drugs

Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on prescription drugs this year, a new report says.
USA Today
19d

How much does the Wegovy pill cost? Here's how to pay less

WeightWatchers Med+ is now offering an oral GLP-1 medication for weight loss. The new daily pill is the first FDA-approved oral GLP-1 for weight management. Clinical trials showed weight loss results similar to popular injectable GLP-1s. Wegovy has long ...
2d

No Fasting, No Injections: Inside Eli Lilly’s New Weight‑Loss Drug

Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug Administration on April 1, 2026, as an oral glucagon-like peptide-1 receptor for weight management. And it’s been accessed by 20,000 people since its launch.
1d

New UCSF study finds GLP-1 weight loss drugs can lead to hair loss

A study published earlier this month in the journal Science Progress found that GLP-1 drugs were linked to hair loss in patients during periods of fast weight loss. Of these drugs, semaglutide and tirzepatide had the highest rates of hair loss, which include the name brands Ozempic, Wegovy, Mounjaro and Zepbound.
  • Privacy
  • Terms